Mounjaro®
Starting from £179.99/mo
Start journey Learn moreYes — in most cases you will need to pause Mounjaro before a surgical procedure. NHS England advises all patients taking GLP-1 or dual agonist medicines, including tirzepatide, to tell their surgical team and anaesthetist before any operation. The reason centres on how Mounjaro slows gastric emptying, which carries real anaesthetic risk even when you have fasted. This page sets out what the current guidance says, what remains uncertain, and who needs to make the final call for your situation — because that decision belongs with your prescriber, surgeon and anaesthetist, not a webpage.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Mounjaro works partly by slowing the movement of food through the stomach, an effect that contributes to reduced appetite and better blood-sugar regulation. In everyday life, that is precisely the point. Before surgery, it creates a complication. Standard fasting instructions (typically nothing to eat for six hours, clear fluids up to two hours before) assume the stomach clears at a normal rate. For people taking tirzepatide, that assumption may not hold.
If food or liquid remains in the stomach when anaesthesia is induced, there is a risk of pulmonary aspiration, stomach contents entering the airway. This is a serious anaesthetic complication. It is not common, but the anaesthetic community has been alerting surgical teams to the concern since GLP-1 medicines became widely prescribed. The NHS England guidance on weight-management injections is explicit: tell your healthcare team, including your anaesthetist, that you are on this medicine before any procedure. That conversation is not optional.
A question our prescribers hear most weeks is whether a planned operation means treatment needs to stop entirely, or just pausing for a short window. The honest answer: it depends, and that is exactly why the surgical team needs to know.
NHS England's published advice names tirzepatide specifically among the medicines requiring disclosure before surgery. Beyond that, specific stop-time recommendations vary. The Royal College of Anaesthetists and several hospital trusts have published their own interim guidance, and the picture is still evolving as more evidence accumulates. Some anaesthetists have adopted a precautionary approach of pausing weekly injectable GLP-1 medicines for one week before elective procedures; others apply longer windows depending on the dose and procedure type.
What no single webpage can responsibly tell you is how many days or weeks applies to your operation, your current dose and your health history. The timing question genuinely requires a conversation between your prescriber, your surgeon and your anaesthetist. If you started Mounjaro through nume, our prescribers can liaise with your surgical team or write a clinical summary to support that discussion, reach out via our support team and we will help coordinate.
For a detailed look at the clinical reasoning behind the pause recommendation, the explanation of why Mounjaro and surgery interact this way goes further into the mechanism and the anaesthetic considerations.
Pausing tirzepatide sounds simple, but it sits inside a wider picture. If you are using Mounjaro to manage type 2 diabetes as well as weight, stopping without a plan may affect your blood-sugar control. Even for weight management alone, your prescriber needs to know so your treatment record is accurate and your next clinical review accounts for the gap. The practical steps around stopping before surgery cover what to tell your team and what to expect during a planned break.
When you are ready to restart after surgery, the timing and dose need clinical review too. Recovery affects appetite, hydration and gut motility, and your prescriber will want to know how the procedure went before advising when to pick up the pen again. This is not bureaucracy, it is the kind of oversight that makes treatment safe rather than just convenient.
You can read more about Mounjaro and surgery generally, including considerations for emergency procedures, or explore what is known about tirzepatide in pre-operative contexts. The broader picture of what Mounjaro involves is also covered on our Mounjaro treatment page.
If you have an operation planned, the steps are clear. First, tell your surgical team you are taking Mounjaro, include the dose and when you last injected. Second, contact your prescriber (at nume, that means reaching out to us directly) so your treatment can be paused with a clinical note on file. Third, follow fasting instructions from your anaesthetist precisely; do not assume standard fasting covers all bases on this medicine.
For people who have not yet started treatment and are considering Mounjaro while surgery is on the horizon, that is a conversation worth having during your consultation. Our prescribers assess the full picture, and planned surgery is exactly the kind of factor that shapes both the timing and suitability of starting. Starting a free consultation is the right first step, and it puts you in front of a real prescriber the same day, not a decision tree.
If you are weighing up the broader commitment of treatment, our weight-loss treatment overview and the frequently asked questions may help you prepare for that conversation. For more on the clinical team making these decisions, see the clinical team profile.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.